POS0308 LONG-TERM EFFICACY OF MEPOLIZUMAB IN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGI...
POS0308 LONG-TERM EFFICACY OF MEPOLIZUMAB IN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS: A PROPENSITY SCORE MATCHING ANALYSIS IN THE MULTICENTER REVEAL COHORT STUDY
About this item
Full title
Author / Creator
Shiomi, M. , Watanabe, R. , Matsuda, S. , Kotani, T. , Okazaki, A. , Masuda, Y. , Yoshida, T. , Shoji, M. , Tsuge, R. , Kadoba, K. , Hiwa, R. , Yamamoto, W. and Hashimoto, M.
Publisher
Kidlington: BMJ Publishing Group Ltd and European League Against Rheumatism
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: BMJ Publishing Group Ltd and European League Against Rheumatism
Subjects
More information
Scope and Contents
Contents
Background:Mepolizumab (MPZ) has demonstrated efficacy in clinical trials for patients with eosinophilic granulomatosis with polyangiitis (EGPA) [1]; however, there is a limited number of studies comparing the disease course between individuals treated with MPZ (MPZ group) and those who were not treated with MPZ (non-MPZ group) in a real-world sett...
Alternative Titles
Full title
POS0308 LONG-TERM EFFICACY OF MEPOLIZUMAB IN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS: A PROPENSITY SCORE MATCHING ANALYSIS IN THE MULTICENTER REVEAL COHORT STUDY
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3100907466
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3100907466
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2024-eular.1937
